Report ID |
100938 |
Drug Identification Number |
02224569 |
Brand name |
DIABETA |
Common or Proper name |
Diabeta |
Company Name |
SANOFI-AVENTIS CANADA INC |
Market Status |
CANCELLED POST MARKET |
Active Ingredient(s) |
GLYBURIDE |
Strength(s) |
5MG |
Dosage form(s) |
TABLET |
Route of administration |
ORAL |
Packaging size |
30 |
ATC code |
A10BB |
ATC description |
BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS |
Reason for discontinuation |
Business reasons |
Anticipated discontinuation date |
2020-04-30 |
Actual discontinuation date |
2020-05-07 |
Remaining supply date |
2020-04-30 |
Discontinuation status |
Discontinued |
Discontinuation decision reversal |
No |
Information on remaining supply |
|
Company comments |
last lot 8118195 expiry 2020-11-05 |
Health Canada comments |
|
Company contact information |
email: CAINTERNET@sanofi.com
Telephone: 1-800-265-7927 |